Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators
暂无分享,去创建一个
[1] F. DeLeo,et al. Role of NF‐κB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor‐α , 2007 .
[2] T. Kern,et al. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. , 2007, Investigative ophthalmology & visual science.
[3] Yau-Huei Wei,et al. Oxidative Stress, Mitochondrial DNA Mutation, and Apoptosis in Aging , 2007, Experimental biology and medicine.
[4] F. Mascarelli,et al. Placental growth factor-1 and epithelial haemato–retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy , 2007, Diabetologia.
[5] S. Mohr,et al. Inhibition of Caspase-1/Interleukin-1β Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia , 2007, Diabetes.
[6] E. Araki,et al. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. , 2006, Antioxidants & redox signaling.
[7] S. Sizmaz,et al. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy , 2006, Eye.
[8] D. Jump,et al. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. , 2005, Investigative ophthalmology & visual science.
[9] M. Bartoli,et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. , 2005, Current drug targets.
[10] T. Gardner,et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. , 2005, Diabetes.
[11] R. Kowluru,et al. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. , 2004, Investigative ophthalmology & visual science.
[12] Sibel Ülker,et al. Antioxidant vitamins C and E ameliorate hyperglycaemia‐induced oxidative stress in coronary endothelial cells , 2004, Diabetes, obesity & metabolism.
[13] Yunpeng Du,et al. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[14] R. Kowluru,et al. Role of interleukin-1β in the pathogenesis of diabetic retinopathy , 2004, British Journal of Ophthalmology.
[15] M. Simionescu,et al. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. , 2004, Journal of diabetes and its complications.
[16] S. Mohr,et al. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. , 2004 .
[17] S. Mohr. Potential new strategies to prevent the development of diabetic retinopathy , 2004, Expert opinion on investigational drugs.
[18] M. Grant,et al. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. , 2003, Investigative ophthalmology & visual science.
[19] S. Catalano,et al. Oxidative stress in diabetes-induced endothelial dysfunction involvement of nitric oxide and protein kinase C. , 2003, Free radical biology & medicine.
[20] L. Olson,et al. Glucose-induced activation of glucose uptake in cells from the inner and outer blood-retinal barrier. , 2002, Investigative ophthalmology & visual science.
[21] S. Mohr,et al. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.
[22] Mark A. Smith,et al. Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.
[23] Sten Orrenius,et al. Cytochrome c release from mitochondria proceeds by a two-step process , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] T. Bensaoula,et al. Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[25] P. Krammer,et al. FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.
[26] D. Sorescu,et al. Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways , 2001, Circulation research.
[27] H. Utsumi,et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. , 2000, Diabetes.
[28] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[29] Hollifield,et al. Evidence for control of tumour necrosis factor‐alpha (TNF‐α) activity by TNF receptors in patients with proliferative diabetic retinopathy , 1999, Clinical and experimental immunology.
[30] J. Handa,et al. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. , 1999, Investigative ophthalmology & visual science.
[31] G. King,et al. Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.
[32] J. Williamson,et al. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.
[33] A. Mantovani,et al. Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.
[34] C. Distler,et al. Glia Cells of the Monkey Retina—II. Müller Cells , 1996, Vision Research.
[35] M. Lorenzi,et al. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.
[36] W. Fiers,et al. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Brownlee. Glycation and Diabetic Complications , 1994, Diabetes.
[38] B. Glasgow,et al. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. , 1994, Investigative ophthalmology & visual science.
[39] J. Forrester,et al. Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA in bovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture , 1993, Diabetologia.
[40] J. Vilček,et al. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein , 1992, Journal of Neuroimmunology.
[41] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[42] P. Campochiaro,et al. Aldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium , 1988, Diabetes.
[43] R. A. Field,et al. DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS. , 1964, Lancet.
[44] Chowne. CHARING-CROSS HOSPITAL.: ABSTRACT OF THE INTRODUCTORY LECTURE , 1843 .
[45] R. Kowluru,et al. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. , 2004, The British journal of ophthalmology.
[46] A. Sevinç,et al. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. , 2002, Eye.
[47] G. Lutty,et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. , 1998, Free radical biology & medicine.
[48] M. Brownlee. Lilly Lecture 1993. Glycation and diabetic complications. , 1994, Diabetes.
[49] D. Lefer,et al. Endothelial and Myocardial Cell Protection by a Cysteine‐Containing Nitric Oxide Donor After Myocardial Ischemia and Reperfusion , 1993, Journal of cardiovascular pharmacology.